Plunkett Research Online: Polynovo

POLYNOVO (CALZF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Polynovo Ltd develops innovative medical devices for several medical applications, utilizing the patented biodegradable polymer technology NovoSorb. NovoSorb is a family of proprietary medical-grade polymers that can be utilized to manufacture novel medical devices designed to support tissue repair .....



Polynovo
Ticker: CALZF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 386814050
Fax: 61 386814099
Address: 320 Lorimer Street
Unit 2
Port Melbourne, VIC 3207 Australia

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing
Contacts Description
David WilliamsChairman of the Board/Director
Robyn ElliottDirector
See More
Polynovo Ltd develops innovative medical devices for several medical applications, utilizing the patented biodegradable polymer technology NovoSorb. NovoSorb is a family of proprietary medical-grade polymers that can be utilized to manufacture novel medical devices designed to support tissue repair .....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: